Herbert leads Aspira Labs as its laboratory director. Before his tenure at Aspira Labs, Dr. Fritsche was a biochemistry professor and chief of the clinical chemistry section in the Department of Pathology and Laboratory Medicine at The University of Texas M.D. Anderson Cancer Center in Houston.
Dr. Fritsche has published over 200 manuscripts in peer-reviewed journals and books in the field of cancer diagnostics. He has served on many scientific journals’ editorial review boards, as an associate editor for the International Journal of Biological Markers and section editor for the Archives of Pathology and Laboratory Medicine. He has been recognized by the American Association for Clinical Chemistry with its Presidential Citation; the Morton K. Schwartz Award for Research and Accomplishments in Cancer Diagnostics; a National Award for Outstanding Contributions in Education, and the Johnson and Johnson Award for Outstanding Research Contributions in clinical biochemistry from the National Academy of Clinical Biochemistry. In 1999, he received the Distinguished Scientist Award from the Clinical Ligand Assay Society, where he also served as president, and in 2015 he received the Abbott-ISOBM outstanding scientist award from the International Society of Oncology and Biomarkers. Dr. Fritsche holds a Doctorate and Master’s degrees in chemistry from Texas A&M University and a Bachelor of Science in chemistry from the University of Houston.